Market Overview:
The global malabsorption syndrome market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The market growth is attributed to the increasing prevalence of gastrointestinal diseases, rising awareness about malabsorption syndrome, and technological advancements in the field of diagnostics and therapeutics. However, the high cost of treatment may restrain the growth of this market during the forecast period. The global malabsorption syndrome market can be segmented on the basis of type, application, and region. On the basis of type, it can be divided into nutritional supplements, protease and lipase supplements, antibiotics, antidiarrheal agents anti-inflammatory drugs,, and others. The nutritional supplements segment is expected to account for a major share in terms of revenue in 2018 owing to its high demand as a treatment for various gastrointestinal disorders such as Crohn’s disease,. ulcerative colitis,, celiac disease,, etc., which often lead to malabsorption syndrome. By application,.the market can be classified into pharmaceutical companies hospitals nutrition clinics academic research institutes among others In terms by region,.
Product Definition:
Malabsorption Syndrome is a disorder that affects the body's ability to absorb food and nutrients from the digestive tract. The syndrome can cause a wide range of symptoms, including diarrhea, weight loss, and malnutrition. Malabsorption Syndrome can be caused by a variety of factors, including infection, surgery, medication side effects, or problems with the digestive tract. The syndrome is often treated with antibiotics or dietary modifications.
Nutritional Supplements:
Nutritional supplements are the food items or substances, which are taken into the human body to replace or enhance particular nutrients that are missing in the diet. The main function of nutritional supplements is not only to provide essential nutrients but also to act as an alternative for those who cannot have dairy products such as calcium and vitamin D.
Protease and Lipase Supplements:
Protease and lipase supplements are used in malabsorption syndrome to help digestion. The main function of the human body is to produce digestive enzymes for breaking down food into nutrients. If there is a problem with the functioning of these enzymes, then it may lead to various health problems including malabsorption syndrome.
Application Insights:
The pharmaceutical companies segment dominated the global malabsorption syndrome market in terms of revenue in 2017. The growth of this segment can be attributed to increasing prevalence of chronic diseases, which require regular medication. According to a study published by the CDC, it was estimated that around 1 in 8 U.S adults were suffering from some form of digestive disorder in 2015. Thus, growing geriatric population and rising incidences of various chronic diseases are expected to drive demand for nutritional supplements over the forecast period.
Nutrition clinics accounted for second-largest share owing to high number of patients visiting such clinics due to lack or improper digestion of foodstuffs consumed by them such as protein, fat.
Regional Analysis:
In 2017, North America accounted for the largest share of global market. The presence of a large number of key players in this region and increasing awareness about GMD are responsible for its dominance. Moreover, the high adoption rate of innovative treatment options is also expected to drive regional growth during the forecast period. Asia Pacific is estimated to be one of the fastest-growing regions over the forecast period owing to rising healthcare expenditure by governments and private sectors in countries such as China, India, South Korea and Japan. In addition, growing medical tourism industry due to affordable treatments offered by GMD providers will further boost demand in this region.
Growth Factors:
- Increasing incidence of gastrointestinal diseases
- Rising awareness about malabsorption syndrome and its treatment options
- Growing number of research and development activities for malabsorption syndrome treatments
- Technological advancements in the diagnosis and treatment of malabsorption syndrome
- increasing prevalence of malnutrition
Scope Of The Report
Report Attributes
Report Details
Report Title
Malabsorption Syndrome Market Research Report
By Type
Nutritional Supplements, Protease and Lipase Supplements, Antibiotics, Antidiarrheal Agents, Anti-inflammatory Drugs, Others
By Application
Pharmaceutical Companies, Hospitals, Nutrition Clinics, Academic And Research Institutes
By Companies
Abbvie, Actelion Pharmaceuticals, Astrazeneca, Bayer Healthcare, Dsm, Eli Lily And Company, Gilead Sciences
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
205
Number of Tables & Figures
144
Customization Available
Yes, the report can be customized as per your need.
Global Malabsorption Syndrome Market Report Segments:
The global Malabsorption Syndrome market is segmented on the basis of:
Types
Nutritional Supplements, Protease and Lipase Supplements, Antibiotics, Antidiarrheal Agents, Anti-inflammatory Drugs, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmaceutical Companies, Hospitals, Nutrition Clinics, Academic And Research Institutes
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbvie
- Actelion Pharmaceuticals
- Astrazeneca
- Bayer Healthcare
- Dsm
- Eli Lily And Company
- Gilead Sciences
Highlights of The Malabsorption Syndrome Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Nutritional Supplements
- Protease and Lipase Supplements
- Antibiotics
- Antidiarrheal Agents
- Anti-inflammatory Drugs
- Others
- By Application:
- Pharmaceutical Companies
- Hospitals
- Nutrition Clinics
- Academic And Research Institutes
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Malabsorption Syndrome Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Malabsorption syndrome is a condition in which the body cannot absorb nutrients from food. This can lead to malnutrition and other health problems.
Some of the major companies in the malabsorption syndrome market are Abbvie, Actelion Pharmaceuticals, Astrazeneca, Bayer Healthcare, Dsm, Eli Lily And Company, Gilead Sciences.
The malabsorption syndrome market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Malabsorption Syndrome Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Malabsorption Syndrome Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Malabsorption Syndrome Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Malabsorption Syndrome Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Malabsorption Syndrome Market Size & Forecast, 2018-2028
4.5.1 Malabsorption Syndrome Market Size and Y-o-Y Growth
4.5.2 Malabsorption Syndrome Market Absolute $ Opportunity
Chapter 5 Global Malabsorption Syndrome Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Malabsorption Syndrome Market Size Forecast by Type
5.2.1 Nutritional Supplements
5.2.2 Protease and Lipase Supplements
5.2.3 Antibiotics
5.2.4 Antidiarrheal Agents
5.2.5 Anti-inflammatory Drugs
5.2.6 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Malabsorption Syndrome Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Malabsorption Syndrome Market Size Forecast by Applications
6.2.1 Pharmaceutical Companies
6.2.2 Hospitals
6.2.3 Nutrition Clinics
6.2.4 Academic And Research Institutes
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Malabsorption Syndrome Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Malabsorption Syndrome Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Malabsorption Syndrome Analysis and Forecast
9.1 Introduction
9.2 North America Malabsorption Syndrome Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Malabsorption Syndrome Market Size Forecast by Type
9.6.1 Nutritional Supplements
9.6.2 Protease and Lipase Supplements
9.6.3 Antibiotics
9.6.4 Antidiarrheal Agents
9.6.5 Anti-inflammatory Drugs
9.6.6 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Malabsorption Syndrome Market Size Forecast by Applications
9.10.1 Pharmaceutical Companies
9.10.2 Hospitals
9.10.3 Nutrition Clinics
9.10.4 Academic And Research Institutes
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Malabsorption Syndrome Analysis and Forecast
10.1 Introduction
10.2 Europe Malabsorption Syndrome Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Malabsorption Syndrome Market Size Forecast by Type
10.6.1 Nutritional Supplements
10.6.2 Protease and Lipase Supplements
10.6.3 Antibiotics
10.6.4 Antidiarrheal Agents
10.6.5 Anti-inflammatory Drugs
10.6.6 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Malabsorption Syndrome Market Size Forecast by Applications
10.10.1 Pharmaceutical Companies
10.10.2 Hospitals
10.10.3 Nutrition Clinics
10.10.4 Academic And Research Institutes
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Malabsorption Syndrome Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Malabsorption Syndrome Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Malabsorption Syndrome Market Size Forecast by Type
11.6.1 Nutritional Supplements
11.6.2 Protease and Lipase Supplements
11.6.3 Antibiotics
11.6.4 Antidiarrheal Agents
11.6.5 Anti-inflammatory Drugs
11.6.6 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Malabsorption Syndrome Market Size Forecast by Applications
11.10.1 Pharmaceutical Companies
11.10.2 Hospitals
11.10.3 Nutrition Clinics
11.10.4 Academic And Research Institutes
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Malabsorption Syndrome Analysis and Forecast
12.1 Introduction
12.2 Latin America Malabsorption Syndrome Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Malabsorption Syndrome Market Size Forecast by Type
12.6.1 Nutritional Supplements
12.6.2 Protease and Lipase Supplements
12.6.3 Antibiotics
12.6.4 Antidiarrheal Agents
12.6.5 Anti-inflammatory Drugs
12.6.6 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Malabsorption Syndrome Market Size Forecast by Applications
12.10.1 Pharmaceutical Companies
12.10.2 Hospitals
12.10.3 Nutrition Clinics
12.10.4 Academic And Research Institutes
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Malabsorption Syndrome Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Malabsorption Syndrome Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Malabsorption Syndrome Market Size Forecast by Type
13.6.1 Nutritional Supplements
13.6.2 Protease and Lipase Supplements
13.6.3 Antibiotics
13.6.4 Antidiarrheal Agents
13.6.5 Anti-inflammatory Drugs
13.6.6 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Malabsorption Syndrome Market Size Forecast by Applications
13.10.1 Pharmaceutical Companies
13.10.2 Hospitals
13.10.3 Nutrition Clinics
13.10.4 Academic And Research Institutes
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Malabsorption Syndrome Market: Competitive Dashboard
14.2 Global Malabsorption Syndrome Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbvie
14.3.2 Actelion Pharmaceuticals
14.3.3 Astrazeneca
14.3.4 Bayer Healthcare
14.3.5 Dsm
14.3.6 Eli Lily And Company
14.3.7 Gilead Sciences
